| abstract |
The present invention provides a pharmaceutical composition for use as a Th2ndifferentiation inhibitor comprising a compound represented by Formula (I):n nwherein each of ring A, ring B and ring C is an aromatic carbocyclic ring, a heterocyclicnring and the like, X is a single bond, -O-, -CH 2 -, -NH-, -SO- and the like, Y is hydrogen,noptionally substituted lower alkyl, optionally substituted lower alkenyl and the like,neach of V 1 and V 2 is a single bond, -O-, -NH-, -OCH 2 - and the like,na prodrug, pharmaceutically acceptable salt or solvate thereof. |